The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...

Acute limb ischemia occurs due to a sudden decrease in the blood flow to a limb, resulting in a potential threat to the viability of the extremity. Unfortunately, the threat is not only to the ...

This study assesses acute ischemic stroke costs in Latin America, revealing treatment variations and economic challenges that ...

A medical device company developing technology to improve outcomes for stroke patients will begin enrollment for a new ...

Results from the trial showed that Revascor reduced cardiovascular mortality and major adverse cardiovascular events. Credit: ...

A TIA, or transient ischemic attack, is a temporary blockage of blood flow to a part of the brain. By definition, a TIA lasts ...

Moyamoya disease (Moyamoya disease) is a disease in which the terminal part of arterial blood vessels in the brain that ...

Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, ...

A new study has demonstrated that a tiny bundle of optical fibers can continuously, accurately, and simultaneously measure ...

Exosomes are a small, specific type of extracellular vesicle (EV), a kind of membrane-enclosed package that can move between ...

The following is a summary of “Optimising the treatment of chronic ischemic heart disease by training general practitioners ...

CardiAMP is a cell therapy commercialized by BioCardia, with a leading Phase III program in Systolic Heart Failure.